2,753
Views
33
CrossRef citations to date
0
Altmetric
Review

The functional roles of exosomes-derived long non-coding RNA in human cancer

, , , , &
Pages 583-592 | Received 15 Jun 2018, Accepted 25 Dec 2018, Published online: 11 Feb 2019

References

  • Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. Ca-Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.21338.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. Ca-Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.21442.
  • Zhu QQ, Li N, Zeng XY, Han QY, Li F, Yang CL, Lv Y, Zhou Z, Liu Z. Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival. Oncotarget. 2015;6:4440–4450. doi:10.18632/oncotarget.2913.
  • Pasut A, Matsumoto A, Clohessy JG, Pandolfi PP. The pleiotropic role of non-coding genes in development and cancer. Curr Opin Cell Biol. 2016;43:104–113. doi:10.1016/j.ceb.2016.10.005.
  • Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekstrom K, Wang XQ, Principe S, Shah N, Ashraf NM, Fatima F, et al. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol. 2014;11:688–701. doi:10.1038/nrurol.2014.301.
  • Ono S, Lam S, Nagahara M, Hoon DSB. Circulating microRNA biomarkers as liquid biopsy for cancer patients: pros and cons of current assays. J Clin Med. 2015;4:1890–1907. doi:10.3390/jcm4101890.
  • Li AC, Zhang TB, Zheng M, Liu YN, Chen Z. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10:175. doi:10.1186/s13045-017-0542-8.
  • Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotec. 2016;14:211–222. doi:10.1016/j.csbj.2016.05.004.
  • Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet. 2010;19:R152–R161. doi:10.1093/hmg/ddq353.
  • Shen XH, Qi P, Du X. Long non-coding RNAs in cancer invasion and metastasis. Modern Pathol. 2015;28:4–13. doi:10.1038/modpathol.2014.75.
  • Chang YN, Zhang K, Hu ZM, Qi HX, Shi ZM, Han XH, Han Y-W, Hong W. Hypoxia-regulated lncRNAs in cancer. Gene. 2016;575:1–8. doi:10.1016/j.gene.2015.08.049.
  • Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15:39. doi:10.1186/s12943-016-0524-4.
  • He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344:20–27. doi:10.1016/j.canlet.2013.10.021.
  • Dong L, Lin WR, Qi P, Xu MD, Wu XB, Ni SJ, Huang D, Weng -W-W, Tan C, Sheng W, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer. Cancer Epidem Biomark. 2016;25:1158–1166. doi:10.1158/1055-9965.EPI-16-0006.
  • Wang T, Qu XY, Jiang JJ, Gao P, Zhao DD, Lian XQ, Li X. Diagnostic significance of urinary long non-coding PCA3 RNA in prostate cancer. Oncotarget. 2017;8:58577–58586. doi:10.18632/oncotarget.17272.
  • Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013;33:3185–3193.
  • Yang F, Bi JW, Xue XC, Zheng LM, Zhi KK, Hua JD, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279:3159–3165. doi:10.1111/j.1742-4658.2012.08694.x.
  • Pang QQ, Ge JX, Shao YF, Sun WL, Song HJ, Xia T, Xiao B, Guo J. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumor Biol. 2014;35:5441–5447. doi:10.1007/s13277-014-1709-3.
  • Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroentero. 2013;19:3658–3664. doi:10.3748/wjg.v19.i23.3658.
  • Liu Z, Shao YF, Tan L, Shi HJ, Chen SC, Guo JM. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumor Biol. 2014;35:9613–9617. doi:10.1007/s13277-014-2259-4.
  • Bussemakers MJG, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HFM, Schalken JA, Debruyne FM, Ru N, Isaacs WB. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59:5975–5979.
  • Schalken J. Molecular diagnostics and therapy of prostate cancer: new avenues. Eur Urol. 1998;34:3–6.
  • Ren SC, Wang FB, Shen J, Sun Y, Xu WD, Lu J, Wei M, Xu C, Wu C, Zhang Z, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013;49:2949–2959. doi:10.1016/j.ejca.2013.04.026.
  • Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764–774. doi:10.18632/oncotarget.1769.
  • Li J, Wang XC, Tang JW, Jiang RQ, Zhang WJ, Ji J, Sun B. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cell Physiol Biochem. 2015;37:687–696. doi:10.1159/000430387.
  • Tang JW, Jiang RQ, Deng L, Zhang XD, Wang K, Sun BC. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget. 2015;6:4505–4515. doi:10.18632/oncotarget.2934.
  • Hu XD, Bao JT, Wang Z, Zhang ZG, Gu PJ, Tao F, Cui D, Jiang W. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumor Biol. 2016;37:3497–3504. doi:10.1007/s13277-015-4023-9.
  • Xu N, Chen F, Wang FL, Lu X, Wang X, Lv MM, Lu C. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study. Tumor Biol. 2015;36:7659–7665. doi:10.1007/s13277-015-3469-0.
  • Yang L, Bai HS, Deng Y, Fan L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmaco. 2015;19:3187–3193.
  • Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim SW, Kim YT. Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol. 2015;46:521–530. doi:10.3892/ijo.2014.2758.
  • Zhang J, Yao TT, Wang YX, Yu J, Liu YY, Lin ZQ. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol Ther. 2016;17:104–113. doi:10.1080/15384047.2015.1108496.
  • Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzas EI, Buck AH, de Candia P, Chow FW, Das S, et al.. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracell Vesicles. 2017;6:1286095. doi:10.1080/20013078.2017.1286095.
  • Nawaz M, Fatima F, Vallabhaneni KC, Penfornis P, Valadi H, Ekstrom K, Zhao Z, Wang L, Zhuo Y, Chen P, et al. Extracellular vesicles: evolving factors in stem cell biology. Stem Cells Int. 2016;2016:1073140. doi:10.1155/2016/1243659.
  • Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32:623–642. doi:10.1007/s10555-013-9441-9.
  • Ibrahim SH, Hirsova P, Tomita K, Bronk SF, Werneburg NW, Harrison SA, Goodfellow VS, Malhi H, Gores GJ. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology. 2016;63:731–744. doi:10.1002/hep.28252.
  • Segura E, Nicco C, Lombard B, Veron P, Raposo G, Batteux F, Amigorena S, Théry C. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood. 2005;106:216–223. doi:10.1182/blood-2005-01-0220.
  • Lu Z, Zuo BF, Jing RW, Gao XJ, Rao Q, Liu ZL, Qi H, Guo H, Yin H. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67:739–748. doi:10.1016/j.jhep.2017.05.019.
  • Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017;6:1400370. doi:10.1080/20013078.2017.1400370.
  • Han C, Sun X, Liu L, Jiang HY, Shen Y, Xu XY, Li J, Zhang G, Huang J, Lin Z, et al. Exosomes and their therapeutic potentials of stem cells. Stem Cells Int. 2016;2016:7653489. doi:10.1155/2016/7653489.
  • Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659. doi:10.1038/ncb1596.
  • Yu SR, Cao HX, Shen B, Feng JF. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget. 2015;6:37151–37168. doi:10.18632/oncotarget.6022.
  • Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–579. doi:10.1038/nri855.
  • Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang HY, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816-826. doi:10.1038/ncb3169.
  • Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329-335. doi:10.1038/nature15756.
  • Wong WY, Lee MML, Chan BD, Kam RKT, Zhang G, Lu AP, Tai WC-S. Proteomic profiling of dextran sulfate sodium induced acute ulcerative colitis mice serum exosomes and their immunomodulatory impact on macrophages. Proteomics. 2016;16:1131–1145. doi:10.1002/pmic.201500174.
  • Escudero CA, Herlitz K, Troncoso F, Acurio J, Aguayo C, Roberts JM, Truong G, Duncombe G, Rice G, Salomon C. Role of extracellular vesicles and microRNAs on dysfunctional angiogenesis during preeclamptic pregnancies. Front Physiol. 2016;7:98. doi:10.3389/fphys.2016.00098.
  • Merino-Gonzalez C, Zuniga FA, Escudero C, Ormazabal V, Reyes C, Nova-Lamperti E, Salomón C, Aguayo C. Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: potencial clinical application. Front Physiol. 2016;7:24. doi:10.3389/fphys.2016.00024.
  • Lener T, Gimona M, Aigner L, Borger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. doi:10.3402/jev.v4.30087.
  • Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126:1152–1162. doi:10.1172/JCI81129.
  • Lee C, Carney RP, Hazari S, Smith ZJ, Knudson A, Robertson CS, Lam KS, Wachsmann-Hogiu S. 3D plasmonic nanobowl platform for the study of exosomes in solution. Nanoscale. 2015;7:9290–9297. doi:10.1039/c5nr01333j.
  • Zhu L, Qu XH, Sun YL, Qian YM, Zhao XH. Novel method for extracting exosomes of hepatocellular carcinoma cells. World J Gastroenterol. 2014;20:6651–6657. doi:10.3748/wjg.v20.i21.6651.
  • Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7:297–303. doi:10.1038/85438.
  • Ramirez MI, Amorim MG, Gadelha C, Milic I, Welsh JA, Freitas VM, Nawaz M, Akbar N, Couch Y, Makin L, et al. Technical challenges of working with extracellular vesicles. Nanoscale. 2018;10:881–906. doi:10.1039/c7nr08360b.
  • Helwa I, Cai JW, Drewry MD, Zimmerman A, Dinkins MB, Khaled ML, Seremwe M, Dismuke WM, Bieberich E, Stamer WD, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One. 2017;12:e0170628. doi:10.1371/journal.pone.0170628.
  • Gardiner C, Di Vizio D, Sahoo S, Thery C, Witwer KW, Wauben M, Hill AF. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945. doi:10.3402/jev.v5.32945.
  • Kamerkar S, LeBleu VS, Sugimoto H, Yang SJ, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498–503. doi:10.1038/nature22341.
  • Kosaka N. Decoding the secret of cancer by means of extracellular vesicles. J Clin Med. 2016;5:22. doi:10.3390/jcm502002.
  • Silverman JM, Clos J, De’Oliveira CC, Shirvani O, Fang Y, Wang C, Foster LJ, Reiner NE. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci. 2010;123:842–852. doi:10.1242/jcs.056465.
  • Ratajczak MZ, Ratajczak J. Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later. Clin Transl Med. 2016;5:7. doi:10.1186/s40169-016-0087-4.
  • Desrochers LM, Antonyak MA, Cerione RA. Extracellular vesicles: satellites of information transfer in cancer and stem cell biology. Dev Cell. 2016;37:301–309. doi:10.1016/j.devcel.2016.04.019.
  • Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–1789. doi:10.1101/gr.132159.111.
  • Fatima F, Nawaz M. Vesiculated long non-coding RNAs: offshore packages deciphering trans-regulation between cells, cancer progression and resistance to therapies. Noncoding RNA. 2017;3:10. doi:10.3390/ncrna3010010.
  • Wu Y, Lyu H, Liu HB, Shi XF, Song Y, Liu BL. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer. Sci Rep-Uk. 2016;6:31093. doi:10.1038/srep31093.
  • Sun CC, Li SJ, Zhang F, Xi YY, Wang L, Bi YY, Li D. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget. 2016;7:51784–51814. doi:10.18632/oncotarget.10108.
  • Zhang R, Xia YH, Wang ZX, Zheng J, Chen YF, Li XL, Wang Y, Ming H. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Bioph Res Co. 2017;490:406–414. doi:10.1016/j.bbrc.2017.06.055.
  • Wang SH, Li XX, Zhu RJ, Han Q, Zhao RC. Lung cancer exosomes initiate global long non-coding RNA changes in mesenchymal stem cells. Int J Oncol. 2016;48:681–689. doi:10.3892/ijo.2015.3272.
  • Ohno S, Tachibana M, Fujii T, Ueda S, Kubota H, Nagasue N. Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma. Int J Cancer. 2002;97:770–774.
  • Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer. 2003;2:14. doi:10.1186/1476-4598-2-14.
  • Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: A mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013;4:261–272. doi:10.1177/1947601913499020.
  • Xue M, Chen W, Xiang A, Wang RQ, Chen H, Pan JJ, Pang H, An H, Wang X, Hou H, et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Mol Cancer. 2017;16:143. doi:10.1186/s12943-017-0714-8.
  • Arscott WT, Tandle AT, Zhao SP, Shabason JE, Gordon IK, Schlaff CD, Zhang G, Tofilon PJ, Camphausen KA. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol. 2013;6:638–648.
  • Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–1476. doi:10.1038/ncb1800.
  • Lang HL, Hu GW, Chen Y, Liu Y, Tu W, Lu YM, Wu L, Xu GH. Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. Eur Rev Med Pharmaco. 2017;21:959–972.
  • Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP, Fan ST. Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153–166. doi:10.1016/j.ccr.2008.01.013.
  • Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24:2840–2850. doi:10.1634/stemcells.2006-0114.
  • Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M, et al. CD90+liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155. doi:10.1186/s12943-015-0426-x.
  • Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C, et al. Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res. 2015;75:3181–3191. doi:10.1158/0008-5472.CAN-14-3721.
  • Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M, Slaby O. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 2016;7:622–637. doi:10.18632/oncotarget.5807.
  • Wang WL, Xing CE. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer. Pathol Res Pract. 2016;212:690–695. doi:10.1016/j.prp.2016.05.003.
  • Nie FQ, Yu X, Huang MD, Wang YF, Xie M, Ma HW, Wang Z, De W, Sun M. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget. 2017;8:38227–38238. doi:10.18632/oncotarget.9611.
  • Karlsson O, Rodosthenous RS, Jara C, Brennan KJ, Wright RO, Baccarelli AA, Wright RJ. Detection of long non-coding RNAs in human breastmilk extracellular vesicles: implications for early child development. Epigenetics-Us. 2016;11:721–729. doi:10.1080/15592294.2016.1216285.
  • Pan L, Liang W, Fu M, Huang ZH, Li X, Zhang W, Zhang P, Qian H, Jiang P-C, Xu W-R, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin. 2017;143:991–1004. doi:10.1007/s00432-017-2361-2.
  • Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35(Suppl):S185–S198. doi:10.1016/j.semcancer.2015.03.004.
  • Chen J, Wang S, Jia S, Ding G, Jiang G, Cao L. Integrated analysis of long non-coding RNA and mRNA expression profile in pancreatic cancer derived exosomes treated dendritic cells by microarray analysis. J Cancer. 2018;9:21–31. doi:10.7150/jca.21749.
  • Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66:1–9. doi:10.1016/j.critrevonc.2007.07.004.
  • Wu QF, Wu XL, Ying X, Zhu QY, Wang XJ, Jiang L, Chen X, Wu Y, Wang X. Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA. Cancer Cell Int. 2017;17:62. doi:10.1186/s12935-017-0430-x.
  • Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao YH, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11–22. doi:10.1016/j.ccr.2010.05.026.
  • Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, Fatah R, Lee AM, Lister TA, Gribben JG. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood. 2009;114:3909–3916. doi:10.1182/blood-2009-02-206946.
  • Wang YL, Wang YT, Li JF, Zhang YZ, Yin HL, Han B. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015;367:122–128. doi:10.1016/j.canlet.2015.03.027.
  • Liu T, Zhang X, Gao SY, Jing FM, Yang YM, Du LT, Zheng G, Li P, Li C, Wang C. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 2016;7:85551–85563. doi:10.18632/oncotarget.13465.
  • Chen MS, Xu R, Ji H, Greening DW, Rai A, Izumikawa K, Ishikawa H, Takahashi N, Simpson RJ. Transcriptome and long noncoding RNA sequencing of three extracellular vesicle subtypes released from the human colon cancer LIM1863 cell line. Sci Rep-Uk. 2016;6:38397. doi:10.1038/srep38397.
  • Chan SL, Wong VWS, Qin SK, Chan HLY. Infection and cancer: the case of hepatitis B. J Clin Oncol. 2016;34:83–90. doi:10.1200/JCO.2015.61.5724.
  • Zhang C, Yang X, Qi Q, Gao YH, Wei Q, Han SW. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma. Cancer Biomark. 2018;21:651–659. doi:10.3233/CBM-170727.
  • Zhang J, Liu SC, Luo XH, Tao GX, Guan M, Yuan H, Hu D-K. Exosomal long noncoding RNAs are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients. J Clin Lab Anal. 2016;30:1116–1121. doi:10.1002/jcla.21990.
  • Ahadi A, Khoury S, Losseva M, Tran N. A comparative analysis of lncRNAs in prostate cancer exosomes and their parental cell lines. Genom Data. 2016;9:7–9. doi:10.1016/j.gdata.2016.05.010.
  • Ahadi A, Brennan S, Kennedy PJ, Hutvagner G, Tran N. Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes. Sci Rep-Uk. 2016;6:24922. doi:10.1038/srep24922.
  • Ozkan TA. Re: exosomal Lncrna-P21 levels may help to distinguish prostate cancer from benign disease. J Urol Surg. 2015;2:201. doi:10.4274/jus.2015.04.002.
  • Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T, Rosenberg A, Fucile C, Richheimer S, Beckham CJ. Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS One. 2016;11:e0147236. doi:10.1371/journal.pone.0147236.
  • Xu CG, Yang MF, Ren YQ, Wu CH, Wang LQ. Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. Eur Rev Med Pharmacol Sci. 2016;20:4362–4368.
  • Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1237–1248. doi:10.1002/hep.24504.
  • Takahashi K, Yan IK, Wood J, Haga H, Patel T. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014;12:1377–1387. doi:10.1158/1541-7786.MCR-13-0636.
  • Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014;4:458–467. doi:10.1016/j.fob.2014.04.007.
  • Takahashi K, Yan IK, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci. 2014;127:1585–1594. doi:10.1242/jcs.141069.
  • Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653–668. doi:10.1016/j.ccell.2016.03.004.
  • Wang JH, Zheng YJ, Zhao M. Exosome-based cancer therapy: implication for targeting cancer stem cells. Front Pharmacol. 2017;7:533. doi:10.3389/fphar.2016.00533.
  • Shen YY, Guo DF, Weng LX, Wang SJ, Ma ZY, Yang YS, Wang P, Wang J, Cai Z. Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway. Oncoimmunology. 2017;6:e1362527. doi:10.1080/2162402X.2017.1362527.
  • Zhang W, Xia WJ, Lv ZY, Xin Y, Ni C, Yang L. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes? Cell Physiol Biochem. 2017;41:755–768. doi:10.1159/000458736.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.